Skip to main content
Livermore
Livermore
ZHEN

E Fund Management Co., Ltd.

SEC CIK
0001842296
Latest filing
Aug 10, 2026

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings

Shares (Q2 2026)
37,452
Value
$374.5K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of BCRX by E Fund Management Co., Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202637,452$374.5K<0.1%−7,080−15.9%ReducedHolders
Q1 202644,532$423.9K<0.1%–No prior filingHolders
Q3 2025––––Not filedHolders
Q2 202533,592$301.0K<0.1%+9,918+41.9%AddedHolders
Q1 202523,674$177.6K<0.1%+7,062+42.5%AddedHolders
Q4 202416,612$124.9K<0.1%−7,226−30.3%ReducedHolders
Q3 202423,838$181.2K<0.1%−4,447−15.7%ReducedHolders
Q2 202428,285$174.8K<0.1%−45,895−61.9%ReducedHolders
Q1 202474,180$376.8K<0.1%+22,863+44.6%AddedHolders
Q4 202351,317$307.4K<0.1%+9,820+23.7%AddedHolders
Q3 202341,497$294.0K<0.1%−10,926−20.8%ReducedHolders
Q2 202352,423$369.0K<0.1%+5,838+12.5%AddedHolders
Q1 202346,585$389.0K<0.1%+6,330+15.7%AddedHolders
Q4 202240,255$462.0K<0.1%+4,838+13.7%AddedHolders
Q3 202235,417$446.0K<0.1%−8,991−20.2%ReducedHolders
Q2 202244,408$470.0K<0.1%+27,767+166.9%AddedHolders
Q1 202216,641$271.0K<0.1%+1,756+11.8%AddedHolders
Q4 202114,885$206.0K<0.1%+3,536+31.2%AddedHolders
Q3 202111,349$163.0K<0.1%–No prior filingHolders
Q2 2021––––Not filedHolders
Q1 202110,970$112.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.